Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new study, completing a “handshake” that may show the cells are ready for trials in humans with degenerative eye disorders.
Research News
UW Researcher Receives Grant to Expand Knowledge of Molecules Regulating Retinal Function
Mrinalini Hoon, PhD, has been granted a $150,000 Research to Prevent Blindness (RPB) Career Advancement Award.
New Research May Shed Light on Impact of Toxic Metals on Aging Dogs
New research led by a University of Wisconsin–Madison assistant professor could shed some light on whether toxic metals commonly found in and around the home could impact an older dog’s vision and overall health.
UW-Madison Launches New Ophthalmology Tissue Biobank
The University of Wisconsin Department of Ophthalmology and Visual Sciences (DOVS) has entered into a new partnership aimed at systematically collecting, storing, processing and distributing human eye tissue for research purposes.
New nanoparticles aid sepsis treatment in mice
Tens of millions of people worldwide are affected by diseases like macular degeneration or have had accidents that permanently damage the light-sensitive photoreceptors within their retinas that enable vision.
Introducing the 2022 Kambara Symposium Keynote Speaker: Maureen Neitz
A highly accomplished vision scientist and expert in colorblindness has been announced as the keynote speaker for the 2022 George Kambara, MD Vision Science Symposium. Maureen Neitz, PhD is the Ray H. Hill Endowed Chair …
Meet the Newest DOVS Faculty Member: Shaoqin (Sarah) Gong
The UW Department of Ophthalmology and Visual Sciences is pleased to welcome Shaoqin (Sarah) Gong, PhD, as our newest faculty member. Gong comes to DOVS with more than 20 years of experience as a scientist, …
Micro-molded ‘ice cube tray’ scaffold is next step in returning sight to injured retinas
In new research published today, UW–Madison researchers reported a new nanoparticle-based treatment for sepsis that delivers anti-inflammatory molecules and antibiotics.
Treating Antimicrobial Resistant Infections: A Nano-scale Approach with Big Impacts
Antimicrobial-resistant (AMR) infections are predicted to kill 10 million people each year by 2050—up from 700,000 in 2019—and force 24 million people into extreme poverty as early as 2030. Yet, the pharmaceutical industry has divested from the antibiotic resistance crisis, investing instead in more lucrative types of drugs.